source
- Cue Biopharma's chronic hives drug clears Phase 2 trial, first immunology data after cancer pivotCue Biopharma announced that its candidate for chronic spontaneous urticaria successfully completed a Phase 2 trial in China. The trial marks the company's first clinical data since it shifted its…
- FDA to replace animal testing terms with broader nonclinical language in regulationsThe U.S. Food and Drug Administration announced it will revise its regulations to replace references to animal testing with broader terms such as "nonclinical tests" and "nonclinical studies". The…